The general markets have not exactly been on a roll since the beginning of the year, with the Dow Jones Industrial Average recording just a 1.6 percent gain and the Nasdaq Composite index posting a 5.7 percent jump in value. Despite that lukewarm performance, it hasn't put a damper on the red hot biotech sector, which continues its steady upward climb.